Isabella C. Russell

Isabella C. Russell

Auto-generated profile, based on publicly available information

Isabella C. Russell

Research School of Chemistry Australian National University Canberra 2601 Australian Capital Territory Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
MBMattia Belotti
Mattia Belotti
MEMohsen M. T. El‐Tahawy
Mohsen M. T. El‐Tahawy
LYLi‐Juan Yu
Li‐Juan Yu
IRIsabella C. Russell
Isabella C. Russell
Nadim DarwishNadim Darwish
Nadim Darwish
Simone CiampiSimone Ciampi
Simone Ciampi
Luciferin is one of Nature's most widespread luminophores, and enzymes that catalyze luciferin luminescence are the basis of successful commercial “glow” assays for gene expression and metabolic ATP formation. Herein we report an electrochemical method to promote firefly's luciferin luminescence in the absence of its natural biocatalyst—luciferase. We have gained experimental and computational insights on the mechanism of the enzyme‐free luciferin electrochemiluminescence, demonstrated its spectral tuning from green to red by means of electrolyte engineering, proven that the colour change does not require, as still debated, a keto/enol isomerization of the light emitter, and gained evidence of the electrostatic‐assisted stabilization of the charge‐transfer excited state by double layer electric fields. Luciferin's electrochemiluminescence, as well as the in situ generation of fluorescent oxyluciferin, are applied towards an optical measurement of diffusion coefficients.

4 April 2025 in Pharmacological Reviews
Verified
Journal Article
Open access
IRIsabella C. Russell
Isabella C. Russell
DLDongju Lee
Dongju Lee
DWDenise Wootten
Denise Wootten
PSPatrick M Sexton
Patrick M Sexton
FBFabian Bumbak
Fabian Bumbak
G protein-coupled receptors (GPCRs) are critically important medicinal targets, and the cryogenic electron microscopy (cryo-EM) revolution is providing novel high-resolution GPCR structures at a rapid pace. Orphan G protein-coupled receptors (oGPCRs) are a group of approximately 100 nonolfactory GPCRs for which endogenous ligands are unknown or not validated. The absence of modulating ligands adds difficulties to understanding the physiologic significance of oGPCRs and in the determination of high-resolution structures of isolated receptors that could facilitate drug discovery. Despite the challenges, cryo-EM structures of oGPCR-G protein complexes are emerging. This is being facilitated by numerous developments to stabilize GPCR-G protein complexes such as the use of dominant-negative G proteins, mini-G proteins, complex-stabilizing nanobodies or antibody fragments, and protein tethering methods. Moreover, many oGPCRs are constitutively active, which can facilitate complex formation in the absence of a known activating ligand. Consequently, in addition to providing templates for drug discovery, active oGPCR structures shed light on constitutive GPCR activation mechanisms. These comprise self-activation, whereby mobile extracellular portions of the receptor act as tethered agonists by occupying a canonical orthosteric-binding site in the transmembrane core, constitutive activity due to alterations to conserved molecular switches that stabilize inactive states of GPCRs, as well as receptors activated by cryptic ligands that are copurified with the receptor. Cryo-EM structures of oGPCRs are now being determined at a rapid pace and are expected to be invaluable tools for oGPCR drug discovery. SIGNIFICANCE STATEMENT: Orphan G protein-coupled receptors (GPCRs) provide large untapped potential for development of new medicines. Many of these receptors display constitutive activity, enabling structure determination and insights into observed GPCR constitutive activity including (1) self-activation by mobile receptor extracellular portions that function as tethered agonists, (2) modification of conserved motifs canonically involved in receptor quiescence and/or activation, and (3) activation by cryptic lipid ligands. Collectively, these studies advance fundamental understanding of GPCR function and provide opportunities for novel drug discovery.

25 October 2022 in Angewandte Chemie
Verified
Journal Article
Open access
MBMattia Belotti
Mattia Belotti
MEMohsen M. T. El‐Tahawy
Mohsen M. T. El‐Tahawy
LYLi‐Juan Yu
Li‐Juan Yu
IRIsabella C. Russell
Isabella C. Russell
Nadim DarwishNadim Darwish
Nadim Darwish
Simone CiampiSimone Ciampi
Simone Ciampi
Luciferin is one of Nature's most widespread luminophores, and enzymes that catalyze luciferin luminescence are the basis of successful commercial “glow” assays for gene expression and metabolic ATP formation. Herein we report an electrochemical method to promote firefly's luciferin luminescence in the absence of its natural biocatalyst—luciferase. We have gained experimental and computational insights on the mechanism of the enzyme‐free luciferin electrochemiluminescence, demonstrated its spectral tuning from green to red by means of electrolyte engineering, proven that the colour change does not require, as still debated, a keto/enol isomerization of the light emitter, and gained evidence of the electrostatic‐assisted stabilization of the charge‐transfer excited state by double layer electric fields. Luciferin's electrochemiluminescence, as well as the in situ generation of fluorescent oxyluciferin, are applied towards an optical measurement of diffusion coefficients.

5 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
BCBrian P. Cary
Brian P. Cary
EGElliot J. Gerrard
Elliot J. Gerrard
MBMatthew J. Belousoff
Matthew J. Belousoff
MFMadeleine M. Fletcher
Madeleine M. Fletcher
YJYan Jiang
Yan Jiang
PSPatrick M Sexton
Patrick M Sexton
The parathyroid hormone (PTH) 1 receptor (PTH1R) is a class B1 G protein-coupled receptor (GPCR) that critically regulates skeletal development and calcium homeostasis. Despite extensive study, the molecular underpinnings of PTH1R stimulation by its cognate hormones, as well as by therapeutic agents, remain unclear. Here, we describe cryo-EM structures of the PTH1R in complex with active fragments of the two hormones, PTH and parathyroid hormone related protein (PTHrP), the peptidic drug abaloparatide, as well as the engineered tool compounds, long-acting PTH (LA-PTH) and the truncated peptide, M-PTH(1-14). We found that the N-terminus of each agonist that is critical for activity, engages the transmembrane bundle in a topologically similar fashion, which reflects similarities in measures of Gαs activation. The full-length peptides bind the extracellular domain (ECD) using a shared interface but induce subtly different ECD orientations relative to the transmembrane domain (TMD). In the structure bound to M-PTH, an agonist which only binds the TMD, the ECD is completely unresolved, demonstrating that the ECD is highly dynamic when unconstrained by a peptide. High resolutions enabled identification of water molecules near the peptide and G protein binding sites, some of which are structurally conserved with other class B1 GPCRs. Our results shed light on the action of orthosteric agonists of the PTH1R and provide a foundation for structure based-drug design.

27 October 2022 in Angewandte Chemie
Verified
Journal Article
Closed access
MBMattia Belotti
Mattia Belotti
MEMohsen M. T. El‐Tahawy
Mohsen M. T. El‐Tahawy
LYLi‐Juan Yu
Li‐Juan Yu
IRIsabella C. Russell
Isabella C. Russell
Nadim DarwishNadim Darwish
Nadim Darwish
Simone CiampiSimone Ciampi
Simone Ciampi

27 October 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
MBMattia Belotti
Mattia Belotti
MEMohsen M. T. El‐Tahawy
Mohsen M. T. El‐Tahawy
LYLi‐Juan Yu
Li‐Juan Yu
IRIsabella C. Russell
Isabella C. Russell
Nadim DarwishNadim Darwish
Nadim Darwish
Simone CiampiSimone Ciampi
Simone Ciampi